Myeong Geun Choi

Natural Killer Cells as a Potential Biomarker for Predicting Immunotherapy Efficacy in Patients with Non-Small Cell Lung Cancer

Yong‐Hee Cho, Myeong Geun Choi, Dong Ha Kim et al. · Targeted Oncology · 2020 · 50 citations

Life Sciences, Immunology, Oncology +17

Different prognostic implications of hepatic metastasis according to front-line treatment in non-small cell lung cancer: a real-world retrospective study

Myeong Geun Choi, Chang‐Min Choi, Sang‐We Kim et al. · Translational Lung Cancer Research · 2021 · 30 citations · Full text

Medicine, Oncology, Chemotherapy +13

A Phase I/IIa Randomized Trial Evaluating the Safety and Efficacy of SNK01 Plus Pembrolizumab in Patients with Stage IV Non-Small Cell Lung Cancer

Eo Jin Kim, Yong‐Hee Cho, Dong Ha Kim et al. · Cancer Research and Treatment · 2021 · 28 citations · Full text

Medicine, Oncology, Pharmacology +17

Changes in blood Krebs von den Lungen-6 predict the mortality of patients with acute exacerbation of interstitial lung disease

Myeong Geun Choi, Sun Mi Choi, Jae Ha Lee et al. · Scientific Reports · 2022 · 23 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +14

The Risk of Tuberculosis in Patients With Inflammatory Bowel Disease Treated With Vedolizumab or Ustekinumab in Korea

Myeong Geun Choi, Byong Duk Ye, Suk‐Kyun Yang et al. · Journal of Korean Medical Science · 2022 · 22 citations · Full text

Public Health, Infectious Diseases, Pharmacotherapy +17